COVIDIEN EVERFLEX SELF-EXPANDING PERIPHERAL STENT WITH ENTRUST DELIVERY SYSTEM LONG; STENT, SUPERFICIAL FEMORAL ARTERY
|
Back to Search Results |
|
Model Number EVD35-06-150-120 |
Device Problems
Migration or Expulsion of Device (1395); Activation, Positioning or Separation Problem (2906)
|
Patient Problem
Insufficient Information (4580)
|
Event Date 03/30/2023 |
Event Type
Injury
|
Event Description
|
It was reported that an attempt was made to treat a calcified lesion in the right proximal superficial femoral artery with an everflex entrust self-expanding stent.No degree of tortuosity.Moderate degree of calcification.Unknown degree of stenosis.5fr 45cm, non medtronic sheath was used.035 glide advantage, and a non medtronic guide wire was used.Embolic protection was not used.Device prepped per ifu.It was reported that deployment issues occurred (partial deployment).There was no damage to the deployment mechanisms or device handle prior to deployment issue.Thumbscrew/lock-pin was checked for securement prior to procedure.Lock-pin was removed after stent catheter was in place, right before deployment.The lesion was predilated with a 5mm pre-dilation device.The device did not pass through a previously deployed stent.Resistance was not encountered when advancing the device.Excessive force was not used.After only partial deployment, the physician continued to try to deploy with wheel, the tech then removed strain relief and opened the handle to manually deploy.The string on wheel was severed and all tangled up.They attempted to pull copper catheter and it finally released and deployed with much difficulty.Profunda artery became jailed, procedure was aborted and patient was admitted to hospital for removal of stent.No further patient injury reported for this event.
|
|
Manufacturer Narrative
|
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Search Alerts/Recalls
|
|
|